Breast cancer


Potential advance in HER+ patients with combination therapy

Non-chemotherapy-based combination therapies may play a possible role for the treatment of women with HER2-positive (HER2+) tumours, as by selectively targeting a specific group of patients, there is a greater opportunity to achieve control of…

Read More